Back
ProQR Therapeutics NV Vs. Freshpet Industry Stock Comparison
Buy
53
PRQR
ProQR Therapeutics NV
Last Price:
1.94
Seasonality Move:
6.7%
Buy
73
FRPT
Freshpet
Last Price:
126.52
Seasonality Move:
7.62%
Buy
53
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $1.94. The Score for PRQR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
Freshpet (FRPT)
is a Buy
Is Freshpet a Buy, Sell or Hold?
- The current Freshpet [FRPT] share price is $126.65. The Score for FRPT is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- FRPT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $1.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.
FRPT Stock Price Chart
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 42.28 | Sell |
| Chaikin Money Flow: | -45529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.93 - 2.01) | Sell |
| Bollinger Bands (100): | (1.92 - 2.28) | Sell |
FRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.02 | Buy |
| Relative Strength Index (14 RSI): | 72.27 | Buy |
| Chaikin Money Flow: | -110818 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (103.83 - 121.79) | Buy |
| Bollinger Bands (100): | (88.73 - 115.27) | Buy |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.96 | Sell |
| 20-day SMA: | 1.98 | Sell |
| 50-day SMA: | 2.13 | Sell |
| 200-day SMA: | 1.81 | Buy |
| 8-day EMA: | 1.96 | Sell |
| 20-day EMA: | 1.99 | Sell |
| 50-day EMA: | 2.05 | Sell |
| 200-day EMA: | 1.96 | Sell |
FRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 123.96 | Buy |
| 20-day SMA: | 114.76 | Buy |
| 50-day SMA: | 112.6 | Buy |
| 200-day SMA: | 85.96 | Buy |
| 8-day EMA: | 123.92 | Buy |
| 20-day EMA: | 118.09 | Buy |
| 50-day EMA: | 111.59 | Buy |
| 200-day EMA: | 91.66 | Buy |
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.25 per share.
Freshpet Earnings Growth & FRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.12 per share, an increase this year of $1.26 per share, and an increase next year of $0.22 per share.
ProQR Therapeutics NV Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Freshpet Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||